Latest Remuneration News

Lincoln Minerals Limited has announced a supplementary prospectus to raise an additional $750,000 through a Follow-on Placement, responding to strong investor demand beyond its initial entitlement offer.

Eneco Refresh Limited has appointed Christerpher Conyers as CEO following his instrumental role in returning the company to profitability. His leadership marks a new chapter focused on sustaining growth and operational efficiency.

Coventry Group Ltd has appointed Nik Alpert as Managing Director, marking a key leadership transition with no changes to his existing remuneration package.

Gateway Mining has appointed seasoned geologist Richard Pugh as CEO, aiming to leverage his deep Yandal Project expertise to fast-track exploration and resource expansion.

Fat Prophets Global Contrarian Fund Ltd has reported a robust 56% increase in net profit for the year ended 30 June 2025, driven by strong investment returns and a leveraged global equity portfolio. The company also declared a fully franked special dividend, reflecting confidence in its ongoing performance.

Catalyst Metals Limited reported record FY2025 financial results driven by stable operations at the Plutonic Gold Belt and a buoyant gold price environment. The company plans to double annual gold production to 200koz through development of new mines and expanded exploration.

Excelsior Capital Limited reports a sharp 98% drop in profit after tax for FY25 following the prior year’s $47.2 million gain from selling its CMI Electrical subsidiary. Despite this, the company declared a fully franked final dividend of 4.0 cents per share.

Perpetual Resources has launched a prospectus to enable trading of new options issued alongside a recent $1.6 million placement, aiming to unlock liquidity while outlining key risks for investors.

4DS Memory Limited posted a $9.68 million loss for FY2025 as it advanced its 20nm ReRAM technology, encountering manufacturing setbacks that prompted a detailed root cause analysis. The company secured $8 million in capital to support ongoing development and strategic partnerships.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Burgundy Diamond Mines posted a $29.5 million net loss for H1 2025, driven by operational disruptions and weaker diamond prices, leading to a temporary halt of mining at Point Lake. The company is navigating liquidity challenges with new financing arrangements while restructuring its operations.

8common Limited reported a significant narrowing of its net loss for FY25 alongside a 16% growth in SaaS revenue and improved gross margins, positioning the company for profitability in FY26.